Target-Dose Versus Below-Target-Dose ACE Inhibitors and Lower Risk of Kidney Failure in U.S. Veterans with HFrEF

20260 citationsJournal Article

Authors

Amiya Ahmed · Georgetown University

Frederick Lu · Brown University

Sijian Zhang · Brown University

V. K. Raman · Georgetown University

Samir S Patel · George Washington University

Charity J. Morgan · Veterans Health Administration

Charles Faselis ·

Abstract

In patients with HFrEF, target-dose (vs. below-target-dose) ACEIs, but not ARBs, were associated with lower risk of KF, which was significant in those with advanced CKD. The survival benefit was modest and limited to those without advanced CKD.

Topics & Keywords

Diabetes Treatment and Management Chronic Kidney Disease and Diabetes Parathyroid Disorders and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: European Journal of Heart Failure

DOI: 10.1093/ejhf/xuag076

Field-Weighted Citation Impact: 0.00